# MEDITOXIN® Treatment in Subjects With Post-Stroke Upper Limb Spasticity

> **NCT03908580** · PHASE4 · COMPLETED · sponsor: **Medy-Tox** · enrollment: 120 (actual)

## Conditions studied

- Spasticity, Muscle

## Interventions

- **DRUG:** Meditoxin

## Key facts

- **NCT ID:** NCT03908580
- **Lead sponsor:** Medy-Tox
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-09-06
- **Primary completion:** 2014-10-31
- **Final completion:** 2015-03-31
- **Target enrollment:** 120 (ACTUAL)
- **Last updated:** 2019-04-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03908580

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03908580, "MEDITOXIN® Treatment in Subjects With Post-Stroke Upper Limb Spasticity". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT03908580. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*